Alvimopan metabolite (ADL08-0011),hydrochloride salt

Alvimopan metabolite (ADL08-0011),hydrochloride salt Suppliers list
Company Name: Shenzhen Botel Biotechnology Co. Ltd.  
Tel: 0755-22202135 13316968096
Email: 1979313431@qq.com
Products Intro: Product Name:Alvimopan metabolite (ADL08-0011),hydrochloride salt
Purity:98% HPLC Package:10mg;25mg;50mg
Company Name: Beijing Biocreative Technology Co., Ltd.  
Tel: 15522676233
Email: 3007606172@qq.com
Products Intro: Product Name:ADL 08-0011 HCl
CAS:170098-43-8
Purity:>98% Package:mg
Company Name: Shanghai Yiyan Biotechnology Co. , Ltd.  
Tel: 021-69985186 13611928337
Email: 3427709316@qq.com
Products Intro: Product Name:ADL 08-0011 (hydrochloride)
CAS:170098-43-8
Company Name: Shanghai Yifei Biotechnology Co. , Ltd.  
Tel: 021-65675885 18964387627
Email: customer_service@efebio.com
Products Intro: Product Name:ADL 08-0011 (hydrochloride)
CAS:170098-43-8
Purity:90% Package:1mg;5mg;10mg
Company Name: guoyungurui  
Tel: 18162595016
Email: 3287908757@qq.com
Products Intro: Product Name:Alvimopan metabolite (ADL08-0011),hydrochloride salt
CAS:170098-43-8
Purity:95%+HPLC Package:10mg;25mg;50mg;100mg;200mg
Alvimopan metabolite (ADL08-0011),hydrochloride salt Basic information
Product Name:Alvimopan metabolite (ADL08-0011),hydrochloride salt
Synonyms:Alvimopan metabolite (ADL08-0011),hydrochloride salt;Alvimopan Metabolite 1 (ADL 08-0011) HCl;Alvimopan Impurity 21;ADL 08-0011 (hydrochloride)
CAS:170098-43-8
MF:C23H30ClNO3
MW:403.95
EINECS:
Product Categories:
Mol File:170098-43-8.mol
Alvimopan metabolite (ADL08-0011),hydrochloride salt Structure
Alvimopan metabolite (ADL08-0011),hydrochloride salt Chemical Properties
storage temp. -20°C
solubility DMSO: soluble,Methanol: soluble
form A solid
Safety Information
MSDS Information
Alvimopan metabolite (ADL08-0011),hydrochloride salt Usage And Synthesis
Biological ActivityADL 08-0011 is an active metabolite of the μ-opioid receptor antagonist alvimopan .1 It is produced from alvimopan via amide hydrolysis by gut microbiota. ADL 08-0011 is a μ-opioid receptor antagonist (Ki = 0.25 nM). It is selective for μ-opioid receptors over κ- and δ-opioid receptors (Kis = 15.8 and 31.6 nM, respectively). ADL 08-0011 inhibits endomorphin 1-induced inhibition of electrically induced contraction of isolated guinea pig ileum (pA2 = 9.4). In vivo, ADL 08-0011 (0.03-1 mg/kg) reverses loperamide-induced delayed gastric emptying in a rat model of castor oil-induced diarrhea.2
References1.Beattie, D.T., Cheruvu, M., Mai, N., et al.The in vitro pharmacology of the peripherally restricted opioid receptor antagonists, alvimopan, ADL 08-0011 and methylnaltrexoneNaunyn Schmiedebergs Arch. Pharmacol.375(3)205-220(2007) 2.Armstrong, S.R., Campbell, C.B., Richardson, C.L., et al.The in vivo pharmacodynamics of the novel opioid receptor antagonist, TD-1211, in models of opioid-induced gastrointestinal and CNS activityNaunyn Schmiedebergs Arch Pharmacol.386(6)471-478(2013)
Alvimopan metabolite (ADL08-0011),hydrochloride salt Preparation Products And Raw materials
Tag:Alvimopan metabolite (ADL08-0011),hydrochloride salt(170098-43-8) Related Product Information